The First Judicial District of Pennsylvania recently granted a motion to create a Xarelto litigation mass tort program in Philadelphia. This follows the establishment of a Xarelto multidistrict litigation (MDL) in Louisiana in December.
Xarelto is prescribed to treat atrial fibrillation and to reduce blood clot risk. About 130,000 patients were prescribed Xarelto in the U.S. during the first quarter of 2012, according to the Huffington Post.
Anyone who suffered internal bleeding while taking Xarelto, an anticoagulant, may be eligible to file a Xarelto lawsuit against Bayer HealthCare Pharmaceuticals and Johnson & Johnson’s Janssen Pharmaceuticals division. The current lawsuits allege manufacturers failed to warn patients to monitor their blood levels to determine bleeding risk and adjust dosage if necessary. Failure to check blood levels can put patients at risk for internal bleeding which can lead to death or extended hospitalization. Currently, there is no antidote to reverse the effects of Xarelto bleeding.
If you or a loved one experienced bleeding from Xarelto, contact a Xarelto lawyer to find out if you qualify for compensation. Filing a Xarelto lawsuit can force the manufacturers to take responsibility for injuries caused by the dangerous drug.